Abstract
Cadmium is an established human and animal carcinogen. Most evidence is available for elevated risk for lung cancer after occupational exposure; however, associations between cadmium exposure and tumors at other locations including kidney, breast, and prostate may be relevant as well. Furthermore, enhanced cancer risk may not be restricted to comparatively high occupational exposure, but may also occur via environmental exposure, for example in areas in close proximity to zinc smelters. The underlying mechanisms are still a matter of manifold research activities. While direct interactions with DNA appear to be of minor importance, elevated levels of reactive oxygen species (ROS) have been detected in diverse experimental systems, presumably due to an inactivation of detoxifying enzymes. Also, the interference with proteins involved in the cellular response to DNA damage, the deregulation of cell growth as well as resistance to apoptosis appears to be involved in cadmium-induced carcinogenicity. Within this context, cadmium has been shown to disturb nucleotide excision repair, base excision repair, and mismatch repair. Particularly sensitive targets appear to be proteins with zinc-binding structures, present in DNA repair proteins such as XPA, PARP-1 as well as in the tumor suppressor protein p53. Whether or not these interactions are due to displacement of zinc or due to reactions with thiol groups involved in zinc complexation or in other critical positions under realistic exposure conditions remains to be elucidated. Further potential mechanisms relate to the interference with cellular redox regulation, either by enhanced generation of ROS or by reaction with thiol groups involved in the regulation of signaling pathways. Particularly the combination of these multiple mechanisms may give rise to a high degree of genomic instability evident in cadmium-adapted cells, relevant not only for tumor initiation, but also for later steps in tumor development.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BER:
-
base excision repair
- Bw:
-
body weight
- cAMP:
-
cyclic adenosine 3’,5’-monophosphate
- EFSA:
-
European Food Safety Authority
- FAO:
-
Food and Agriculture Organization of the United Nations
- Fpg:
-
formamidopyrimidine DNA glycosylase
- GG-NER:
-
global genome nucleotide excision repair
- GSH:
-
glutathione
- IARC:
-
International Agency for Research on Cancer
- JEM:
-
job-exposure-matrix
- JNK:
-
c-jun-N-terminal kinase
- MAK Commission:
-
(= maximale Arbeitsplatzkonzentration) German Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area
- MAPK:
-
mitogen activated protein kinases
- MMR:
-
mismatch repair
- MT:
-
metallothionein
- NER:
-
nucleotide excision repair
- NF-κB:
-
nuclear factor κB
- Nrf2:
-
NF-E2-related factor
- Ogg1:
-
8-oxoguanine DNA glycosylase 1
- PARP:
-
poly(ADP-ribose) polymerase
- PTWI:
-
provisional tolerable weekly intake
- ROS:
-
reactive oxygen species
- TC-NER:
-
transcription-coupled nucleotide excision repair
- TWI:
-
tolerable weekly intake
- UVC:
-
ultraviolet C light (the full range is 100–280 nm; but usually in biological experiments 254 nm is applied)
- WHO:
-
World Health Organization
- XP:
-
xeroderma pigmentosum
- XPA:
-
xeroderma pigmentosum group A protein
- 8-oxoG:
-
8-oxoguanine
- 8-oxo-dGTPase:
-
8-oxo-dG 5’-triphosphate pyrophosphohydrolase
References
G. F. Nordberg, Toxicol. Appl. Pharmacol. 2009, 238, 192–200.
EFSA, The EFSA Journal 2009, 980, 1–139.
M. Sughis, J. Penders, V. Haufroid, B. Nemery, T. S. Nawrot, Environmental Health: A Global Access Science Source 2011, 10, 104.
IARC, Beryllium, Cadmium, Mercury and Exposures in the Glass Manufacturing Industry, 1993.
IARC, Supplement: Cadmium and Cadmium compounds, 1997.
IARC, A Review of Human Carcinogens; Part C: Arsenic, Metals, Fibres, and Dusts, 2012, pp. 121–145.
Cadmium and Its Compounds (in the form of inhable dusts/aerosols), Vol. 22, The MAK Collection for Occupational Health and Safety, Ed H. Greim, Wiley-VCH, Weinheim, Germany, 2006.
L. Stayner, R. Smith, T. Schnorr, R. Lemen, M. Thun, Ann. Epidemiol. 1993, 3, 114–116.
T. Sorahan, N. A. Esmen, Occupat. Environ. Med. 2004, 61, 108–116.
T. Sorahan, Occupat. Med. 2009, 59, 264–266.
L. Jarup, T. Bellander, C. Hogstedt, G. Spang, Occupat. Environ.M. 1998, 55, 755–759.
T. Nawrot, M. Plusquin, J. Hogervorst, H. A. Roels, H. Celis, L. Thijs, J. Vangronsveld, E. Van Hecke, J. A. Staessen, The Lancet Oncology 2006, 7, 119–126.
B. Pesch, J. Haerting, U. Ranft, A. Klimpel, B. Oelschlägel, W. Schill, Int. J. Epidemiol. 2000, 29, 1014–1024.
J. Hu, Y. Mao, K. White, Occupat. Med. 2002, 52, 157–164.
J. Siemiatycki, Risk Factors for Cancer in the Workplace, CRC Press, Boca Raton, Florida, 1991.
E. Kellen, M. P. Zeegers, E. D. Hond, F. Buntinx, Cancer Detec. Prev. 2007, 31, 77–82.
J. A. McElroy, M. M. Shafer, A. Trentham-Dietz, J. M. Hampton, P. A. Newcomb, J. Natl. Cancer Inst. 2006, 98, 869–873.
A. Akesson, B. Julin, A. Wolk, Cancer Res. 2008, 68, 6435–6441.
S. Takenaka, H. Oldiges, H. Konig, D. Hochrainer, G. Oberdörster, J. Natl. Cancer Inst. 1983, 70, 367–373.
U. Glaser, D. Hochrainer, F. J. Otto, H. Oldiges, Toxicol. Environ. Chem. 1990, 27, 153–162.
U. Heinrich, L. Peters, H. Ernst, S. Rittinghausen, C. Dasenbrock, H. König, Exp. Pathol. 1989, 37, 253–258.
J. Huff, R. M. Lunn, M. P. Waalkes, L. Tomatis, P. F. Infante, Int. J. Occupat. Environ. Health 2007, 13, 202–212.
D. Beyersmann, A. Hartwig, Arch. Toxicol. 2008, 82, 493–512.
M. Filipic, T. Fatur, M. Vudrag, Hum. Exp. Toxicol. 2006, 25, 67–77.
M. Waisberg, P. Joseph, B. Hale, D. Beyersmann, Toxicology 2003, 192, 95–117.
M. Filipic, T. K. Hei, Mutat. Res. 2004, 546, 81–91.
J. T. Tapisso, C. C. Marques, L. Mathias Mda, G. Ramalhinho Mda, Mutat. Res. 2009, 678, 59–64.
M. Valko, C. J. Rhodes, J. Moncol, M. Izakovic, M. Mazur, Chem. Biol. Interact. 2006, 160, 1–40.
J. Cadet, T. Douki, J. L. Ravanat, Free Radical Biol. Med. 2010, 49, 9–21.
T. B. Kryston, A. B. Georgiev, P. Pissis, A. G. Georgakilas, Mutat. Res. 2011, 711, 193–201.
J. Liu, W. Qu, M. B. Kadiiska, Toxicol. Appl. Pharmacol. 2009, 238, 209–214.
H. Dally, A. Hartwig, Carcinogenesis 1997, 18, 1021–1026.
T. Schwerdtle, F. Ebert, C. Thuy, C. Richter, L. H. Mullenders, A. Hartwig, Chem. Res. Toxicol. 2010, 23, 432–442.
T. Ochi, M. Ohsawa, Mutat. Res. 1985, 143, 137–142.
S. J. Stohs, D. Bagchi, E. Hassoun, M. Bagchi, J. Environ. Pathol. Toxicol. Oncol. 2001, 20, 77–88.
M. Valko, C. J. Rhodes, J. Moncol, M. Izakovic, M. Mazur, Chem. Biol. Interact. 2006, 160, 1–40.
F. Thevenod, Toxicol. Appl. Pharmacol. 2009, 238, 221–239.
M. Genestra, Cell Signal. 2007, 19, 1807–1819.
R. Hakem, EMBO J. 2008, 27, 589–605.
U. Camenisch, H. Naegeli, EXS 2009, 99, 111–150.
M. Christmann, M. T. Tomicic, W. P. Roos, B. Kaina, Toxicology 2003, 193, 3–34.
M. Fousteri, L. H. Mullenders, Cell Res. 2008, 18, 73–84.
A. Hartwig, Environ. Health Perspect. 1994, 102 Suppl 3, 45–50.
C. Giaginis, E. Gatzidou, S. Theocharis, Toxicol. Appl. Pharmacol. 2006, 213, 282–290.
A. Hartwig, Biometals 2010, 23, 951–960.
P. Koedrith, Y. R. Seo, Int. J. Mol. Sci. 2011, 12, 9576–9595.
M. Filipic, Mutat. Res. 2012, 733, 69–77.
J. de Boer, J. H. Hoeijmakers, Carcinogenesis 2000, 21, 453–460.
A. Hartmann, G. Speit, Environ. Mol. Mutagen. 1996, 27, 98–104.
R. D. Snyder, G. F. Davis, P. J. Lachmann, Biol. Trace El. Res. 1989, 21, 389–398.
J. P. Mackay, M. Crossley, Trends Biochem. Sci. 1998, 23, 1–4.
A. Hartwig, Antioxid. Redox Signal. 2001, 3, 625–634.
A. Witkiewicz-Kucharczyk, W. Bal, Toxicol. Lett. 2006, 162, 29–42.
M. Asmuss, L. H. Mullenders, A. Hartwig, Toxicol. Lett. 2000, 112–113, 227–231.
M. Hartmann, A. Hartwig, Carcinogenesis 1998, 19, 617–621.
G. W. Buchko, N. J. Hess, M. A. Kennedy, Carcinogenesis 2000, 21, 1051–1057.
E. Kopera, T. Schwerdtle, A. Hartwig, W. Bal, Chem. Res. Toxicol. 2004, 17, 1452–1458.
T. Fatur, T. T. Lah, M. Filipic, Mutat. Res. 2003, 529, 109–116.
K. Bialkowski, K. S. Kasprzak, Nucleic Acids Res. 1998, 26, 3194–3201.
D. O. Zharkov, T. A. Rosenquist, DNA Repair (Amst) 2002, 1, 661–670.
R. J. Potts, R. D. Watkin, B. A. Hart, Toxicology 2003, 184, 189–202.
I. Hamann, C. König, C. Richter, G. Jahnke, A. Hartwig, Mutat. Res. 2011, May 13 Epub ahead of print; Mutat. Res. 2012, 736, 56–63.
A. Bravard, A. Campalans, M. Vacher, B. Gouget, C. Levalois, S. Chevillard, J. P. Radicella, Mutat. Res. 2010, 685, 61–69.
C. K. Youn, S. H. Kim, D. Y. Lee, S. H. Song, I. Y. Chang, J. W. Hyun, M. H. Chung, H. J. You, J. Biol. Chem. 2005, 280, 25185–25195.
R. K. Kothinti, A. B. Blodgett, D. H. Petering, N. M. Tabatabai, Toxicol. Appl. Pharmacol. 2010, 244, 254–262.
K. Bialkowski, A. Bialkowska, K. S. Kasprzak, Carcinogenesis 1999, 20, 1621–1624.
S. Beneke, A. Bürkle, Nucleic Acids Res. 2007, 35, 7456–7465.
S. Petrucco, Nucleic Acids Res. 2003, 31, 6689–6699.
A. Hartwig, M. Asmuss, I. Ehleben, U. Herzer, D. Kostelac, A. Pelzer, T. Schwerdtle, A. Bürkle, Environ. Health Perspect. 2002, 110 Suppl 5, 797–799.
V. O’Brien, R. Brown, Carcinogenesis 2006, 27, 682–692.
P. Hsieh, K. Yamane, Mech. Ageing Dev. 2008, 129, 391–407.
Y. H. Jin, A. B. Clark, R. J. Slebos, H. Al-Refai, J. A. Taylor, T. A. Kunkel, M. A. Resnick, D. A. Gordenin, Nat. Genet. 2003, 34, 326–329.
A. Lutzen, S. E. Liberti, L. J. Rasmussen, Biochem. Biophys. Res. Commun. 2004, 321, 21–25.
M. Wieland, M. K. Levin, K. S. Hingorani, F. N. Biro, M. M. Hingorani, Biochemistry 2009, 48, 9492–9502.
P. Hainaut, M. Hollstein, Adv. Cancer Res. 2000, 77, 81–137.
F. Cao, T. Zhou, D. Simpson, Y. Zhou, J. Boyer, B. Chen, T. Jin, M. Cordeiro-Stone, W. Kaufmann, Toxicol. Appl. Pharmacol. 2007, 218, 174–185.
S. Chatterjee, S. Kundu, S. Sengupta, A. Bhattacharyya, Mutat. Res. 2009, 663, 22–31.
X. Yu, J. S. Sidhu, S. Hong, J. F. Robinson, R. A. Ponce, E. M. Faustman, Toxicol. Sci. 2011, 120, 403–412.
C. Meplan, K. Mann, P. Hainaut, J. Biol. Chem. 1999, 274, 31663–31670.
B. A. Hart, R. J. Potts, R. D. Watkin, Toxicology 2001, 160, 65–70.
P. Joseph, Toxicol. Appl. Pharmacol. 2009, 238, 272–279.
W. Qu, H. Ke, J. Pi, D. Broderick, J. E. French, M. M. Webber, M. P. Waalkes, Environ. Health Perspect. 2007, 115, 1094–1100.
F. Thevenod, Biometals 2010, 23, 857–875.
M. Costa, J. D. Heck, S. H. Robison, Cancer Res. 1982, 42, 2757–2763.
R. M. Evans, P. J. Davies, M. Costa, Cancer Res. 1982, 42, 2729–2735.
U. Heinrich, IARC Sci. Publ. 1992, 405–413.
A. Martelli, E. Rousselet, C. Dycke, A. Bouron, J. M. Moulis, Biochimie 2006, 88, 1807–1814.
R. J. Potts, I. A. Bespalov, S. S. Wallace, R. J. Melamede, B. A. Hart, Toxicology 2001, 161, 25–38.
T. Zhou, X. Jia, R. E. Chapin, R. R. Maronpot, M. W. Harris, J. Liu, M. P. Waalkes, E. M. Eddy, Toxicol. Lett. 2004, 154, 191–200.
P. Lichtlen, W. Schaffner, BioEssays 2001, 23, 1010–1017.
M. Takiguchi, W. E. Achanzar, W. Qu, G. Li, M. P. Waalkes, Exp. Cell Res. 2003, 286, 355–365.
W. C. Prozialeck, P. C. Lamar, Biochim. Biophys. Acta 1999, 1451, 93–100.
W. C. Prozialeck, P. C. Lamar, S. M. Lynch, Toxicol. Appl. Pharmacol. 2003, 189, 180–195.
J. M. Moulis, Biometals 2010, 23, 877–896.
R. Brigelius-Flohe, L. Flohe, Antioxidants & Redox Signaling 2011, 15, 2335–2381.
G. I. Giles, Curr. Pharm. Design 2006, 12, 4427–4443.
P. D. Ray, B. W. Huang, Y. Tsuji, Cell. Signalling 2012, 24, 981–990.
M. Valko, H. Morris, M. T. Cronin, Curr. Med. Chem. 2005, 12, 1161–1208.
C. Byrne, S. D. Divekar, G. B. Storchan, D. A. Parodi, M. B. Martin, Toxicol. Appl. Pharmacol. 2009, 238, 266–271.
C. D. Klaassen, J. Liu, B. A. Diwan, Toxicol. Appl. Pharmacol. 2009, 238, 215–220.
K. P. Singh, R. Kumari, C. Pevey, D. Jackson, J. W. DuMond, Cancer Lett. 2009, 279, 84–92.
Acknowledgments
The author would like to thank Dr. Gunnar Jahnke for critical reading of the manuscript. Research conducted in the author’s laboratory was supported by the Deutsche Forschungsgemeinschaft and by BWPLUS.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Hartwig, A. (2013). Cadmium and Cancer. In: Sigel, A., Sigel, H., Sigel, R. (eds) Cadmium: From Toxicity to Essentiality. Metal Ions in Life Sciences, vol 11. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-5179-8_15
Download citation
DOI: https://doi.org/10.1007/978-94-007-5179-8_15
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-5178-1
Online ISBN: 978-94-007-5179-8
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)